Guy Goodwin News Today

COMPASS Pathways plc (NASDAQ:CMPS) Q4 2023 Earnings Call Transcript February 29, 2024 COMPASS Pathways plc misses on earnings expectations. Reported EPS is $-0.53 EPS, expectations were $-0.37. COMPASS Pathways plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]

CMPS earnings call for the period ending December 31, 2023.

CMPS earnings call for the period ending December 31, 2023.

Initial data from phase 2 safety profile for psilocybin in the treatment of PTSD indicates the treatment is well-tolerated.

By Sabela Ojea Compass Pathways said early data from its post-traumatic stress disorder phase 2 clinical trial showed the psilocybin treatment was well...

The question of whether psychedelic treatments always require psychotherapy is one hotly debated among researchers, and answers -as well as backstories- vary throughout the whole spectrum.

Initial safety findings at 24 hours post dosing were consistent with studies of COMP360 in other psychiatric conditionsLONDON, Dec. 19, 2023 -- Compass Pathways plc , a biotechnology company...

Believed to be first ever psilocybin clinical trial for treatment of bipolar II depressionLONDON, Dec. 06, 2023 -- Compass Pathways plc , a biotechnology company dedicated to accelerating patient...

COMPASS Pathways plc (NASDAQ:CMPS) Q3 2023 Earnings Call Transcript November 4, 2023 Operator: Good day, ladies and gentlemen, and welcome to the COMPASS Pathways Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. As a reminder, this call is being recorded. I would now like to introduce your host […]

Operator: Good day, ladies and gentlemen, and welcome to the COMPASS Pathways Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.